ATP5IF1: A Potential Drug Target for the Treatment of Diabetes and other Chronic Diseases

Target Name: ATP5IF1

NCBI ID: G93974

ATP5IF1

ATP5IF1: A Potential Drug Target for the Treatment of Diabetes and other Chronic Diseases

Abstract:
ATP5IF1, a protein encoded by the gene ATP5IF1, has been identified as a potential drug target for the treatment of diabetes and other chronic diseases. The protein is involved in the synthesis of ATP, which is a crucial energy source for the cell. The study of ATP5IF1 and its potential as a drug target has important implications for the development of new treatments for diabetes and other chronic diseases.

Introduction:
ATP (adenosine triphosphate) is a crucial energy source for the cell. It is the body's primary source of energy and is involved in all cellular processes that require energy. ATP is synthesized fromADP (adenosine diphosphate) and phosphate sources. The synthesis of ATP from ADP and phosphate sources is a complex process that involves various enzymes, including ATP synthase (ATP synthase I and II) and ATPase (ATPase I and II).

ATP synthase is a protein complex that catalyzes the synthesis of ATP from ADP and phosphate sources. It consists of two subunits, ATP synthase I (also known as ATP synthase alpha) and ATP synthase II (also known as ATP synthase beta), which are responsible for the catalytic activity of the protein. ATP synthase I and II are located in the mitochondria and are responsible for the synthesis of ATP from ADP and phosphate sources.

ATP synthase is a critical enzyme for the cell, as it allows the cell to generate energy for cellular processes. Mutations in the ATP synthase gene have been linked to various diseases, including diabetes.

ATP5IF1: A Potential Drug Target

The study of ATP5IF1 has important implications for the development of new treatments for diabetes and other chronic diseases. ATP5IF1 is a protein that is involved in the synthesis of ATP from ADP and phosphate sources. It is a potential drug target, as it can be targeted by small molecules to inhibit its activity.

The study of ATP5IF1 has been conducted in various organisms, including bacteria, yeast, and mammalian cells. Several studies have shown that ATP5IF1 is involved in the synthesis of ATP from ADP and phosphate sources. It is also known to play a role in the regulation of cellular processes, including cell signaling and metabolism.

In addition to its role in the synthesis of ATP, ATP5IF1 is also involved in the regulation of cellular processes. It has been shown to play a role in the regulation of cell signaling, including the regulation of cell proliferation and the regulation of cellular apoptosis.

The potential drug target status of ATP5IF1 is supported by several studies. Several studies have shown that inhibitors of ATP5IF1 can inhibit the activity of ATP synthase, leading to a decrease in cellular ATP levels. These studies suggest that inhibitors of ATP5IF1 may be effective in treating diabetes and other chronic diseases.

Conclusion:
In conclusion, the study of ATP5IF1 has important implications for the development of new treatments for diabetes and other chronic diseases. The protein is involved in the synthesis of ATP from ADP and phosphate sources and is a potential drug target. Several studies have shown that inhibitors of ATP5IF1 can inhibit the activity of ATP synthase, leading to a decrease in cellular ATP levels. Further research is needed to determine the effectiveness of ATP5IF1 as a drug target

Protein Name: ATP Synthase Inhibitory Factor Subunit 1

Functions: Endogenous F(1)F(o)-ATPase inhibitor limiting ATP depletion when the mitochondrial membrane potential falls below a threshold and the F(1)F(o)-ATP synthase starts hydrolyzing ATP to pump protons out of the mitochondrial matrix. Required to avoid the consumption of cellular ATP when the F(1)F(o)-ATP synthase enzyme acts as an ATP hydrolase. Indirectly acts as a regulator of heme synthesis in erythroid tissues: regulates heme synthesis by modulating the mitochondrial pH and redox potential, allowing FECH to efficiently catalyze the incorporation of iron into protoporphyrin IX to produce heme

The "ATP5IF1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ATP5IF1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets